In vitro bioassay investigations of the endocrine disrupting potential of steviol glycosides and their metabolite steviol, components of the natural sweetener Stevia. (15th May 2016)
- Record Type:
- Journal Article
- Title:
- In vitro bioassay investigations of the endocrine disrupting potential of steviol glycosides and their metabolite steviol, components of the natural sweetener Stevia. (15th May 2016)
- Main Title:
- In vitro bioassay investigations of the endocrine disrupting potential of steviol glycosides and their metabolite steviol, components of the natural sweetener Stevia
- Authors:
- Shannon, Maeve
Rehfeld, Anders
Frizzell, Caroline
Livingstone, Christina
McGonagle, Caoimhe
Skakkebaek, Niels E.
Wielogórska, Ewa
Connolly, Lisa - Abstract:
- Abstract: The food industry is moving towards the use of natural sweeteners such as those produced by Stevia rebaudiana due to the number of health and safety concerns surrounding artificial sweeteners. Despite the fact that these sweeteners are natural; they cannot be assumed safe. Steviol glycosides have a steroidal structure and therefore may have the potential to act as an endocrine disruptor in the body. Reporter gene assays (RGAs), H295R steroidogenesis assay and Ca 2+ fluorimetry based assays using human sperm cells have been used to assess the endocrine disrupting potential of two steviol glycosides: stevioside and rebaudioside A, and their metabolite steviol. A decrease in transcriptional activity of the progestagen receptor was seen following treatment with 25, 000 ng/ml steviol in the presence of progesterone (157 ng/ml) resulting in a 31% decrease in progestagen response ( p = <0.01). At the level of steroidogenesis, the metabolite steviol (500–25, 000 ng/ml) increased progesterone production significantly by 2.3 fold when exposed to 10, 000 ng/ml ( p = <0.05) and 5 fold when exposed to 25, 000 ng/ml ( p =<0.001). Additionally, steviol was found to induce an agonistic response on CatSper, a progesterone receptor of sperm, causing a rapid influx of Ca 2+ . The response was fully inhibited using a specific CatSper inhibitor. These findings highlight the potential for steviol to act as a potential endocrine disruptor. Highlights: Potential of Stevia to act as anAbstract: The food industry is moving towards the use of natural sweeteners such as those produced by Stevia rebaudiana due to the number of health and safety concerns surrounding artificial sweeteners. Despite the fact that these sweeteners are natural; they cannot be assumed safe. Steviol glycosides have a steroidal structure and therefore may have the potential to act as an endocrine disruptor in the body. Reporter gene assays (RGAs), H295R steroidogenesis assay and Ca 2+ fluorimetry based assays using human sperm cells have been used to assess the endocrine disrupting potential of two steviol glycosides: stevioside and rebaudioside A, and their metabolite steviol. A decrease in transcriptional activity of the progestagen receptor was seen following treatment with 25, 000 ng/ml steviol in the presence of progesterone (157 ng/ml) resulting in a 31% decrease in progestagen response ( p = <0.01). At the level of steroidogenesis, the metabolite steviol (500–25, 000 ng/ml) increased progesterone production significantly by 2.3 fold when exposed to 10, 000 ng/ml ( p = <0.05) and 5 fold when exposed to 25, 000 ng/ml ( p =<0.001). Additionally, steviol was found to induce an agonistic response on CatSper, a progesterone receptor of sperm, causing a rapid influx of Ca 2+ . The response was fully inhibited using a specific CatSper inhibitor. These findings highlight the potential for steviol to act as a potential endocrine disruptor. Highlights: Potential of Stevia to act as an endocrine disruptor was investigated. Metabolite of Stevia, steviol, induced most significant effects. Steviol decreased progesterone receptor response in RGA. Steviol caused an increase in progesterone production in H295R assay. Steviol induced an agonistic response on CatSper, a progesterone receptor of sperm. … (more)
- Is Part Of:
- Molecular and cellular endocrinology. Volume 427(2016)
- Journal:
- Molecular and cellular endocrinology
- Issue:
- Volume 427(2016)
- Issue Display:
- Volume 427, Issue 2016 (2016)
- Year:
- 2016
- Volume:
- 427
- Issue:
- 2016
- Issue Sort Value:
- 2016-0427-2016-0000
- Page Start:
- 65
- Page End:
- 72
- Publication Date:
- 2016-05-15
- Subjects:
- Endocrine disruptors -- In vitro bioassays -- Steviol -- Reproductive disorders -- CatSper -- Stevia
Endocrinology -- Periodicals
Molecular biology -- Periodicals
Cytology -- Periodicals
Endocrinology -- Periodicals
Hormones -- Periodicals
Endocrinologie -- Périodiques
Cytology
Endocrinology
Molecular biology
Periodicals
573.4 - Journal URLs:
- http://www.sciencedirect.com/science/journal/03037207 ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.mce.2016.03.005 ↗
- Languages:
- English
- ISSNs:
- 0303-7207
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 5900.760000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 797.xml